| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-15,266 | -14,042 | -3,485 | -13,382 | -12,941 | -8,079 | -8,473 | -5,733 | -10,667 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization expense | ||||||||
37 | 32 | 33 | 37 | 40 | 39 | 36 | 33 | 56 |
Stock-based compensation expense | ||||||||
785 | 673 | 571 | 599 | 578 | 395 | 333 | 273 | 200 |
Amortization and accretion of investments | ||||||||
27 | 90 | 165 | 236 | 195 | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Grants receivable | ||||||||
-331 | -88 | 106 | -514 | 22 | -1,224 | 370 | 1,116 | 722 |
Prepaid expenses | ||||||||
-1,628 | - | - | - | 340 | - | - | - | - |
Other assets | ||||||||
-1,032 | - | - | - | 2,208 | - | - | - | - |
Prepaid expenses and other assets | ||||||||
- | - | - | - | - | - | 491 | 1,087 | 318 |
Accounts payable | ||||||||
-154 | 355 | 247 | -3,379 | 2,747 | -403 | -142 | 82 | 596 |
Accrued expenses and other liabilities | ||||||||
-1,934 | 128 | -502 | 1,335 | 1,917 | -1,894 | 459 | 1,433 | -2,278 |
Deferred rent | ||||||||
- | 0 | 0 | 0 | -175 | 28 | 27 | 41 | 41 |
Net cash used in operating activities | ||||||||
-13,568 | -8,042 | -10,735 | -15,367 | -10,599 | -8,030 | -8,621 | -6,074 | -13,092 |
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | ||||||||
- | 7 | 61 | 0 | 37 | 48 | 69 | 116 | 137 |
Proceeds from maturities of short-term investments | ||||||||
15,000 | - | - | - | - | - | - | - | - |
Purchases of short-term investments | ||||||||
- | 9,980 | 9,920 | 0 | 25,050 | - | - | - | - |
Net cash provided by (used in) investing activities | ||||||||
15,000 | 8,608 | 20,839 | 7,000 | -25,087 | -35,769 | -69 | -116 | -137 |
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | ||||||||
- | 12 | 0 | 29 | 11 | - | - | - | - |
Payments of initial public offering costs | ||||||||
- | - | - | - | 150 | - | - | - | - |
Payments of financing costs | ||||||||
16 | - | - | - | - | - | - | - | - |
Payments of initial public offering costs | ||||||||
- | - | - | - | - | - | 7,337 | 333 | 1,706 |
Net cash used in financing activities | ||||||||
-16 | 167 | 0 | 29 | -139 | -862 | 69,068 | -333 | -1,706 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||
- | - | - | - | - | - | - | - | -44 |
Net increase (decrease) in cash and cash equivalents | ||||||||
1,416 | 733 | 10,104 | -8,338 | -35,825 | -44,661 | 60,378 | -6,479 | -14,979 |
Supplemental disclosure of non-cash investing and financing activities: | ||||||||
Deferred financing costs included in accrued expenses and other current liabilities | ||||||||
166 | - | - | - | - | - | - | - | - |
Purchases of property and equipment included in accounts payable | ||||||||
- | - | - | - | - | - | - | - | 110 |
Deferred offering costs included in accounts payable and accrued expenses | ||||||||
- | - | - | - | - | - | 727 | -35 | 413 |